The Effects of Antibodies on Stilbene Excited State Energetics
N-methylaniline (5.46 g, 50 mmol), methyl 5-bromovalerate (11.1 g, 55 mmol), sodium bicarbonate (8.4 g, 100 mmol) and hexamethyl phosphoramide (HMPA, 50 ml) were added into a 250 ml three neck round bottom flask with a magnetic stirring bar. The reaction mixture was stirred under N 2 at 90 °C for 5
hours. Then the reaction mixture was cooled to room temperature and was mixed with 300 ml of H 2 O.
The mixture was extracted with diethylether (4x 80 ml). The organic layer was washed by saturated brine and dried over magnesium sulfate. The solvent was evaporated to give 10.5 g (47 mmol) of yellow oil Synthesis of methyl 5-(N-(4-formylphenyl)-N-methylamino)pentanoate (4) [2] Under N 2 , anhydrous DMF (11.7 g, 160 mmol) was added into a 100 ml 3-neck round bottom flask with a magnetic stirring bar and cooled with an ice bath. Then phosphorous oxychloride (6.02 g, 40 mmol) was added dropwise with stirring. The reaction mixture turned light pink. After 20 min, compound 3 (8.5 g, 40 mmol) was added dropwise. The color of the reaction mixture turned yellow-green. The reaction mixture was stirred at 110 °C for 2 hours and then the reaction mixture was cooled and poured onto ice (100 g).
The mixture was neutralized (pH 7.0) with saturated sodium acetate and store at 4 °C overnight. 
Synthesis of methyl 5-(N-methyl-N-(4-vinylphenyl)amino)pentanoate (5)
Sodium hydride (60 mg, 2.5 mmol) and dry DMSO (1 ml) was added into a 25 ml 3-neck round bottom flask with a magnetic stirring bar. The mixture was heated at 80 °C for 30 min until the generation of gas bubble was ceased. Then the mixture was cooled on an ice bath. Methyl triphenylphosphonium bromide (0.893 g, 2.5 mmol) dissolved in 2 ml of dry DMSO was added dropwise. After 20 min, the reaction mixture was warmed to room temperature. Then, compound 4 (0.62 g, 2.5 mmol) dissolved in 2 ml dry DMSO was added dropwise. The reaction mixture was stirred for 16 hr at room temperature, poured into H 2 O (150 ml) and extracted with diethylether (4x 50 ml). The organic layer was washed with water, saturated brine and dried over sodium sulfate . The diethylether was evaporated and the residue was purified by silica gel flash chromatography (80% n-hexane/20% EtOAc) to afford 0. 
Synthesis of 5-(N-(4-(4-cyanostyryl)phenyl)-N-methylamino)pentanoic acid (2)
Lithium hydroxide monohydrate (84 mg, 2.0 mmol) was dissolved in the mixture of methanol and water (volume ratio 2:1, 1 ml). This solution and compound 5 (124 mg, 0.5 mmol) were added into a 10 ml round bottom flask with a magnetic stirring bar. The reaction was stirred at room temperature for 2 hr.
TLC analysis of the reaction mixture indicated that the hydrolysis reaction was complete. .
Steady-state spectral measurements
Absorption spectra were measure on a HP 8453 spectrometer in PBS (10 mM sodium phosphate, 150 mM NaCl, pH 7.0), 5% DMF cosolvent, at 21 °C. The dissolved oxygen was not purged. For all the absorption measurements, the concentrations of hapten 1 and 2 were kept at 10 µM in the presence of excess antibody binding sites. The absorption spectra of antibody solutions were used as background for correcting the spectra of the corresponding antibody-hapten complex solutions.
Fluorescence spectra were measured on FluoroMax-2 fluorimeter. In a typical experiment, the slits were at 5/5, the spectrum was recorded from a wavelength that is 10 nm longer than the excitation wavelength to 700 nm with increment of 2 nm. The integration time is 1 s. The concentration of 2 was kept at 10 nM, the concentration of 1 was kept at 100 nM, and antibody concentrations were kept around 10 µM.
Fluorescence spectra of antibody solutions were used as background to correct the fluorescence spectra of corresponding antibody-hapten complexes. 
Time-resolved spectroscopy
All time-resolved measurements were made using the time-correlated single-photon counting method. [3] Antibody complexes were prepared using 10 µM of mAb and 5 µM of 2 in PBS (10 mM sodium phosphate, 150 mM NaCl, pH 7.4), with 5% DMF cosolvent. Measurements were obtained by using repetitive excitation by a pulsed laser (frequency doubled output of a Coherent Mira Titanium-Sapphire laser, ca. 2 ps pulsewidth, repetition rate of 3.8 MHz at 440 nm. Fluorescence emission was measured at right angles to the excitation beam and by using a polarizer set at the magic angle (54.7 relative to vertical). Emission was detected at 575 nm (free 2), 525 nm (11G10-2 and 17A4-2), and 500 nm (16E3-2 and 17E3-2) by using a microchannel plate photomultiplier (Hamamatsu R3809U-01) and standard time- 
Crystallography
Fab 11G10 was produced by papain digest as previously described. [4] Crystallization experiments were performed by the sitting drop vapor diffusion method at 22.5°C. The Fab, concentrated to 15mg/ml, was crystallized in presence of 2-fold molar excess of stilbene derivative 1 from 17% PEG 4,000 and 0.2M ammonium sulfate. For data collection, the crystal was flash-cooled to 100K using 25% glycerol as a cryoprotectant. Data were collected in-house using a rotating anode as x-ray source and processed and scaled with HKL2000 (Table 1) . [5] The structure of 11G10 was determined by molecular replacement using Phaser. [6] The model was refined by alternating cycles of model building with the program O [7] and refinement with Refmac5. [8] The final statistics are shown in Table 1 . The quality of the structure was analyzed using the programs MolProbity [9] , WHAT IF, [10] and PROCHECK. [11] Figure 2 was prepared with PyMol. [12] The coordinates and the structure factors are deposited at the PDB under accession code 2G2R. || Val L51 and Val A51 are the only residues in a disallowed region, but both have well-defined electron density. They are in a ? turn, as commonly observed in other antibody structures.
